Low Bone Mineral Density in Hemophiliacs

Area of Science:

• Hematology
• Bone Physiology
• Metabolic Bone Disease

Background:

• Hemophilia A is a genetic bleeding disorder characterized by deficiency in coagulation factor VIII.
• Bone health is a significant concern in patients with hemophilia A, with implications for morbidity.
• Traditional understanding linked poor bone health to lifestyle factors associated with hemophilia.

Purpose of the Study:

• To synthesize current knowledge on bone health in hemophilia A.
• To elucidate the pathogenetic mechanisms underlying bone density reduction in hemophilia A.
• To highlight the role of coagulation factor VIII in bone metabolism.

Main Methods:

• Comprehensive literature review of original research articles.
• Inclusion of meta-analyses and scientific reviews.
• Synthesis of evidence on bone mineral density and factor VIII interactions.

Main Results:

• Patients with hemophilia A exhibit reduced bone mineral density from childhood, leading to osteopenia and osteoporosis.
• Accumulating evidence indicates coagulation factor VIII directly or indirectly influences bone physiology.
• The role of factor VIII extends beyond its hemostatic function to impact skeletal health.

Conclusions:

• Understanding factor VIII's role in bone metabolism is crucial for managing hemophilia A.
• Decreased bone mineral density in hemophilia A is multifactorial, involving factor VIII.
• Emerging non-factor replacement therapies necessitate careful consideration of their impact on bone health.